104 related articles for article (PubMed ID: 24041341)
1. Genetic screening for the predisposition to venous thromboembolism: a cost-utility analysis of clinical practice in the Italian health care system.
Compagni A; Melegaro A; Tarricone R
Value Health; 2013; 16(6):909-21. PubMed ID: 24041341
[TBL] [Abstract][Full Text] [Related]
2. Testing for factor V Leiden in patients with pulmonary or venous thromboembolism: a cost-effectiveness analysis.
Eckman MH; Singh SK; Erban JK; Kao G
Med Decis Making; 2002; 22(2):108-24. PubMed ID: 11958494
[TBL] [Abstract][Full Text] [Related]
3. Economic evaluation of a novel genetic screening test for risk of venous thromboembolism compared with standard of care in women considering combined hormonal contraception in Switzerland.
Sutherland CS; Ademi Z; Michaud J; Schur N; Lingg M; Bhadhuri A; Pache TD; Bitzer J; Suchon P; Albert V; Hersberger KE; Tanackovic G; Schwenkglenks M
BMJ Open; 2019 Nov; 9(11):e031325. PubMed ID: 31699733
[TBL] [Abstract][Full Text] [Related]
4. Should female relatives of factor V Leiden carriers be screened prior to oral contraceptive use? A cost-effectiveness analysis.
Smith KJ; Monsef BS; Ragni MV
Thromb Haemost; 2008 Sep; 100(3):447-52. PubMed ID: 18766261
[TBL] [Abstract][Full Text] [Related]
5. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.
Couturaud F; Duchemin J; Leroyer C; Delahousse B; Abgrall JF; Mottier D;
Thromb Haemost; 2008 Jan; 99(1):223-8. PubMed ID: 18217158
[TBL] [Abstract][Full Text] [Related]
6. Economic analysis of thrombo inCode, a clinical-genetic function for assessing the risk of venous thromboembolism.
Rubio-Terrés C; Soria JM; Morange PE; Souto JC; Suchon P; Mateo J; Saut N; Rubio-Rodríguez D; Sala J; Gracia A; Pich S; Salas E
Appl Health Econ Health Policy; 2015 Apr; 13(2):233-42. PubMed ID: 25652150
[TBL] [Abstract][Full Text] [Related]
7. Multilocus genetic risk scores for venous thromboembolism risk assessment.
Soria JM; Morange PE; Vila J; Souto JC; Moyano M; Trégouët DA; Mateo J; Saut N; Salas E; Elosua R
J Am Heart Assoc; 2014 Oct; 3(5):e001060. PubMed ID: 25341889
[TBL] [Abstract][Full Text] [Related]
8. Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?
Schambeck CM; Schwender S; Haubitz I; Geisen UE; Grossmann RE; Keller F
Thromb Haemost; 1997 Dec; 78(6):1480-3. PubMed ID: 9423798
[TBL] [Abstract][Full Text] [Related]
9. Obstetric complications and pregnancy-related venous thromboembolism: the effect of low-molecular-weight heparin on their prevention in carriers of factor V Leiden or prothrombin G20210A mutation.
Tormene D; Grandone E; De Stefano V; Tosetto A; Palareti G; Margaglione M; Castaman G; Rossi E; Ciminello A; Valdrè L; Legnani C; Tiscia GL; Bafunno V; Carraro S; Rodeghiero F; Simioni P
Thromb Haemost; 2012 Mar; 107(3):477-84. PubMed ID: 22273731
[TBL] [Abstract][Full Text] [Related]
10. Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A mutation versus patients with no mutation.
Kovac M; Mitic G; Mikovic Z; Antonijevic N; Djordjevic V; Mikovic D; Mandic V; Rakicevic L; Radojkovic D
Clin Appl Thromb Hemost; 2010 Feb; 16(1):66-70. PubMed ID: 18796457
[TBL] [Abstract][Full Text] [Related]
11. Influence of single nucleotide polymorphisms on thrombin generation in factor V Leiden heterozygotes.
Segers O; Simioni P; Tormene D; Castoldi E
Thromb Haemost; 2014 Mar; 111(3):438-46. PubMed ID: 24226152
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of screening and extended anticoagulation for carriers of both factor V Leiden and prothrombin G20210A.
Marchetti M; Quaglini S; Barosi G
QJM; 2001 Jul; 94(7):365-72. PubMed ID: 11435632
[TBL] [Abstract][Full Text] [Related]
13. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
[TBL] [Abstract][Full Text] [Related]
14. Thrombin generation and activated protein C resistance in the absence of factor V Leiden correlates with the risk of recurrent venous thromboembolism in women aged 18-65 years.
Sonnevi K; Tchaikovski SN; Holmström M; Rosing J; Bremme K; Lärfars G
Thromb Haemost; 2011 Nov; 106(5):901-7. PubMed ID: 21947267
[TBL] [Abstract][Full Text] [Related]
15. Do hospital doctors test for thrombophilia in patients with venous thromboembolism?
Samim D; Marques-Vidal P; Alberio L; Waeber G; Méan M
J Thromb Thrombolysis; 2018 Aug; 46(2):238-243. PubMed ID: 29922879
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics of patients with factor V Leiden or prothrombin G20210A and a first episode of venous thromboembolism. Findings from the RIETE Registry.
Gadelha T; Roldán V; Lecumberri R; Trujillo-Santos J; del Campo R; Poggio R; Monreal M;
Thromb Res; 2010 Oct; 126(4):283-6. PubMed ID: 20627204
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of recurrent venous thromboembolism in patients with Factor V Leiden mutation in heterozygous form.
Sveinsdottir SV; Saemundsson Y; Isma N; Gottsäter A; Svensson PJ
Thromb Res; 2012 Sep; 130(3):467-71. PubMed ID: 22512897
[TBL] [Abstract][Full Text] [Related]
18. Can a change in screening and prescribing practice reduce the risk of venous thromboembolism in women taking the combined oral contraceptive pill?
Mills A; Wilkinson C; Fotherby K
Br J Fam Plann; 1998 Jan; 23(4):112-5. PubMed ID: 9882763
[TBL] [Abstract][Full Text] [Related]
19. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
Haentjens P; De Groote K; Annemans L
Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
[TBL] [Abstract][Full Text] [Related]
20. Screening and prevention of venous thromboembolism in critically ill patients: a decision analysis and economic evaluation.
Sud S; Mittmann N; Cook DJ; Geerts W; Chan B; Dodek P; Gould MK; Guyatt G; Arabi Y; Fowler RA; ;
Am J Respir Crit Care Med; 2011 Dec; 184(11):1289-98. PubMed ID: 21868500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
